Development of donepezil-induced hypokalemia following treatment of cognitive impairment
Donepezil is a cholinesterase inhibitor used extensively to treat Alzheimer disease. The increased cholinergic activity is associated with adverse effects, therefore gastrointestinal symptoms, including nausea, vomiting, and diarrhea, are common. Hypokalemia is a rare adverse event that occurs in le...
Main Authors: | Dongryul Kim, Hye Eun Yoon, Hoon Suk Park, Seok Joon Shin, Bum Soon Choi, Byung Soo Kim, Tae Hyun Ban |
---|---|
Format: | Article |
Language: | English |
Published: |
Yeungnam University College of Medicine
2021-01-01
|
Series: | Yeungnam University Journal of Medicine |
Subjects: | |
Online Access: | http://www.e-yujm.org/upload/pdf/yujm-2020-00269.pdf |
Similar Items
-
Clinical Assessment of Alzheimer’s Disease and Response to Donepezil Treatment
by: Serge Gauthier
Published: (2020-12-01) -
Delirium associated with donepezil in a patient with Alzheimer's disease: a case report.
by: Kamyar Mollazadeh-Moghaddam, et al.
Published: (2013-03-01) -
Delirium Associated with Donepezil in a Patient with Alzheimer’s Disease: a Case Report
by: Kamyar Mollazadeh-Moghaddam, et al.
Published: (2013-03-01) -
Ultrasound of the diaphragm in severe hypokalemia induced diaphragmatic dysfunction
by: Gentle Sunder Shrestha, et al.
Published: (2017-01-01) -
Hypocalcemia and hypokalemia due to hyperventilation syndrome in spinal anesthesia -A case report-
by: Hyun Soo Moon, et al.
Published: (2011-12-01)